PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION Trademark
Trademark Overview
On Tuesday, March 22, 2016, a trademark application was filed for PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION trademark a serial number of 86949110. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 4, 2017. This trademark is owned by NPS Pharmaceuticals, Inc.. The PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia
General Information
Serial Number | 86949110 |
Word Mark | PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION |
Filing Date | Tuesday, March 22, 2016 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Saturday, February 4, 2017 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "PARATHYROID (RDNA ORIGIN) FOR INJECTION" |
Description of Mark | The mark consists of the letters "PREOTACT" in uppercase letters above "parathyroid hormone (rDNA origin) for injection". Curved lines are behind and below the words. |
Goods and Services | Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, March 28, 2016 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | SHIRE-NPS PHARMACEUTICALS, INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | LEXINGTON, MA 02421 |
Party Name | NPS Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Bedminster, NJ 07921 |
Trademark Events
Event Date | Event Description |
Monday, February 6, 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Saturday, February 4, 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, August 10, 2016 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Monday, August 8, 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, August 8, 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, August 4, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, July 7, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, July 7, 2016 | NON-FINAL ACTION E-MAILED |
Thursday, July 7, 2016 | NON-FINAL ACTION WRITTEN |
Thursday, June 30, 2016 | ASSIGNED TO EXAMINER |
Tuesday, March 29, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, March 28, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, March 25, 2016 | NEW APPLICATION ENTERED IN TRAM |